The mGlu2/3 receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing-Reference-Cited by-同舟云学术

The mGlu2/3 receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing

Published:2000-07 Issue:2-3 Volume:400 Page:221-224
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Cartmell Jayne,Monn James A,Schoepp Darryle D

Publisher

Elsevier BV

Subject

Pharmacology

Reference12 articles.

1. d-Amphetamine, cocaine and caffeine: a comparative study of acute effects on locomotor activity and behavioural patterns in rats;Antoniou;Neurosci. Biobehav. Rev.,1998

2. Differential effects of classical and newer antipsychotics on the hypermotility induced by two dose levels of d-amphetamine;Arnt;Eur. J. Pharmacol.,1995

3. The mGlu2/3 receptor agonists, LY354740 and LY379268, selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats;Cartmell;J. Pharmacol. Exp. Ther.,1999

4. Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist LY379268, and comparison to the atypical antipsychotic clozapine;Cartmell;Psychopharmacology,2000

5. Pharmacology and functions of metabotropic glutamate receptors;Conn;Annu. Rev. Pharmacol. Toxicol.,1997

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetic regulation of metabotropic glutamate 2/3 receptors: Potential role for ultra-resistant schizophrenia?;Pharmacology Biochemistry and Behavior;2023-08

2. The G Protein-Coupled Glutamate Receptors as Novel Molecular Targets in Schizophrenia Treatment—A Narrative Review;Journal of Clinical Medicine;2021-04-02

3. Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia;Neuropharmacology;2020-02

4. Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disorders;Pharmacology & Therapeutics;2019-01

5. Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression;Neuropharmacology;2018-09